Search research articles
Contact Us
Filters
Showing results (181-190 of 247) with videos related to
Page
of 25
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 9, 2008
Pharmacokinetics of intravenous polymyxin B in critically ill patients
Alexandre P Zavascki, Luciano Z Goldani, Guoying Cao, et al.
Journal of Global Antimicrobial Resistance
|
May 23, 2021
Pharmacodynamics of ceftazidime plus tobramycin combination dosage regimens against hypermutable Pseudomonas aeruginosa isolates at simulated epithelial lining fluid concentrations in a dynamic in vitro infection model
Jessica R Tait, Hajira Bilal, Tae Hwan Kim, et al.
International Journal of Antimicrobial Agents
|
May 4, 2025
Effects of different resistance mechanisms on bacterial response to meropenem, ciprofloxacin, and their combination described by next-generation mechanism-based modelling
Alice E Terrill, Jessica R Tait, Kate E Rogers, et al.
The Journal of Antimicrobial Chemotherapy
|
January 15, 2015
The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model
Rebekah Henry, Bethany Crane, David Powell, et al.
The Journal of Antimicrobial Chemotherapy
|
March 15, 2013
Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy
Siow-Chin Heng, Monica A Slavin, Daoud Al-Badriyeh, et al.
The Journal of Antimicrobial Chemotherapy
|
June 11, 2013
Pharmacokinetics of four different brands of colistimethate and formed colistin in rats
Hui He, Ji-Chang Li, Roger L Nation, et al.
Antimicrobial Agents and Chemotherapy
|
January 6, 2017
High-Dose Ampicillin-Sulbactam Combinations Combat Polymyxin-Resistant Acinetobacter baumannii in a Hollow-Fiber Infection Model
Justin R Lenhard, Nicholas M Smith, Zackery P Bulman, et al.
Antimicrobial Agents and Chemotherapy
|
August 15, 2018
Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients
Vanessa E Rees, Rajbharan Yadav, Kate E Rogers, et al.
The Journal of Antimicrobial Chemotherapy
|
February 26, 2015
Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance
Neang S Ly, Jürgen B Bulitta, Gauri G Rao, et al.
Antimicrobial Agents and Chemotherapy
|
February 12, 2014
Clinical population pharmacokinetics and toxicodynamics of linezolid
Lauren M Boak, Craig R Rayner, M Lindsay Grayson, et al.
Page
of 25
Search research articles
Search
Showing results (181-190 of 247) with videos related to
Sort By:
Page
of 25
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 9, 2008
Pharmacokinetics of intravenous polymyxin B in critically ill patients
Alexandre P Zavascki, Luciano Z Goldani, Guoying Cao, et al.
Journal of Global Antimicrobial Resistance
|
May 23, 2021
Pharmacodynamics of ceftazidime plus tobramycin combination dosage regimens against hypermutable Pseudomonas aeruginosa isolates at simulated epithelial lining fluid concentrations in a dynamic in vitro infection model
Jessica R Tait, Hajira Bilal, Tae Hwan Kim, et al.
International Journal of Antimicrobial Agents
|
May 4, 2025
Effects of different resistance mechanisms on bacterial response to meropenem, ciprofloxacin, and their combination described by next-generation mechanism-based modelling
Alice E Terrill, Jessica R Tait, Kate E Rogers, et al.
The Journal of Antimicrobial Chemotherapy
|
January 15, 2015
The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model
Rebekah Henry, Bethany Crane, David Powell, et al.
The Journal of Antimicrobial Chemotherapy
|
March 15, 2013
Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy
Siow-Chin Heng, Monica A Slavin, Daoud Al-Badriyeh, et al.
The Journal of Antimicrobial Chemotherapy
|
June 11, 2013
Pharmacokinetics of four different brands of colistimethate and formed colistin in rats
Hui He, Ji-Chang Li, Roger L Nation, et al.
Antimicrobial Agents and Chemotherapy
|
January 6, 2017
High-Dose Ampicillin-Sulbactam Combinations Combat Polymyxin-Resistant Acinetobacter baumannii in a Hollow-Fiber Infection Model
Justin R Lenhard, Nicholas M Smith, Zackery P Bulman, et al.
Antimicrobial Agents and Chemotherapy
|
August 15, 2018
Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients
Vanessa E Rees, Rajbharan Yadav, Kate E Rogers, et al.
The Journal of Antimicrobial Chemotherapy
|
February 26, 2015
Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance
Neang S Ly, Jürgen B Bulitta, Gauri G Rao, et al.
Antimicrobial Agents and Chemotherapy
|
February 12, 2014
Clinical population pharmacokinetics and toxicodynamics of linezolid
Lauren M Boak, Craig R Rayner, M Lindsay Grayson, et al.
Page
of 25